We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Michael Weber MD

Michael A Weber MD

Professor of Medicine at the SUNY Downstate College of Medicine in Brooklyn, New York

Dr. Weber is Professor of Medicine at the SUNY Downstate College of Medicine in Brooklyn, New York.  He received his medical degree from Sydney University in Australia.   

His career has been focused primarily on hypertension and preventive cardiology.  He has published numerous research articles in the medical literature and has authored or edited 16 books.  Together with Dr. Suzanne Oparil, he is responsible for the widely used reference volume, Hypertension.

Dr. Weber is the Editor-in-Chief of The Journal of Clinical Hypertension.  Dr. Weber was one of the founders of The American Society of Hypertension and has served as its President.  He also served as Chair of the ASH Hypertension Specialists Program.  He is a Fellow of The American College of Physicians, The American College of Cardiology and The American Heart Association.  He has served on the Cardiovascular and Renal Drugs Advisory Board of the Food and Drug Administration, and continues as a consultant to that Agency.  He has also served for ten years as Chairman of the Formulary Committee of a major pharmacy benefits provider serving many of the leading health plans in the United States. 

His main current research interests are in clinical trials of patients at high risk of cardiovascular events or strokes.  He is also participating actively in trials in patients with metabolic disorders such as diabetes and kidney disease.   Dr. Weber currently serves on the Steering Committees of several national and international clinical outcomes trials.